Neurofibromatosis type 2 (NF2) is a genetically determined tumor-predisposing syndrome. Ocular manifestations include cataracts, epiretinal membranes, retinal hamartomas, optic disk gliomas, and optic nerve sheath meningiomas. Moreover, optic disk edema, optical atrophy, motility disorders, pupil and lid dysfunction, and neurotrophic keratitis can be observed as indirect signs. An observational study was conducted with the aim to collect clinical data and describe the most frequent NF2 ocular manifestations. Fourteen patients affected by NF2, according to the Manchester criteria, were enrolled. All patients underwent complete ophthalmologic and orthoptic evaluation and a spectral domain optical coherence tomography. Ocular manifestations were present in all patients. The slit lamp evaluation of the anterior segment highlighted cataracts in five patients, keratitis in two patients, corneal leukoma in two patients, and corneal pannus in one patient. Fundus oculi and OCT evaluation identified epiretinal membranes in four patients, vitreoretinal tufts in three patients, optic nerve edema in one patient, and retinal hamartoma in one patient. Moreover, the orthoptic evaluation identified different types of ocular motility disorders in seven patients. This is a descriptive study of a rare disease with poor previous literature. Clinical data are shown, emphasizing the role of NF2-specific ophthalmological and orthoptic findings to help establish an early diagnosis.

Ophthalmic manifestation in neurofibromatosis type 2 / Armentano, Marta; Lucchino, Luca; Alisi, Ludovico; Chicca, ANTONIO VALERIO; DI MARTINO, Valerio; Miraglia, Emanuele; Iannetti, Ludovico; Comberiati, Anna Maria; Giustini, Sandra; Lambiase, Alessandro; Moramarco, Antonietta. - In: APPLIED SCIENCES. - ISSN 2076-3417. - 13:10(2023). [10.3390/app13106304]

Ophthalmic manifestation in neurofibromatosis type 2

Marta Armentano
Co-primo
;
Luca Lucchino
Co-primo
;
Ludovico Alisi
Secondo
;
Antonio Valerio Chicca;Valerio Di Martino;Emanuele Miraglia;Ludovico Iannetti;Anna Maria Comberiati;Sandra Giustini;Alessandro Lambiase
Penultimo
;
Antonietta Moramarco
Ultimo
2023

Abstract

Neurofibromatosis type 2 (NF2) is a genetically determined tumor-predisposing syndrome. Ocular manifestations include cataracts, epiretinal membranes, retinal hamartomas, optic disk gliomas, and optic nerve sheath meningiomas. Moreover, optic disk edema, optical atrophy, motility disorders, pupil and lid dysfunction, and neurotrophic keratitis can be observed as indirect signs. An observational study was conducted with the aim to collect clinical data and describe the most frequent NF2 ocular manifestations. Fourteen patients affected by NF2, according to the Manchester criteria, were enrolled. All patients underwent complete ophthalmologic and orthoptic evaluation and a spectral domain optical coherence tomography. Ocular manifestations were present in all patients. The slit lamp evaluation of the anterior segment highlighted cataracts in five patients, keratitis in two patients, corneal leukoma in two patients, and corneal pannus in one patient. Fundus oculi and OCT evaluation identified epiretinal membranes in four patients, vitreoretinal tufts in three patients, optic nerve edema in one patient, and retinal hamartoma in one patient. Moreover, the orthoptic evaluation identified different types of ocular motility disorders in seven patients. This is a descriptive study of a rare disease with poor previous literature. Clinical data are shown, emphasizing the role of NF2-specific ophthalmological and orthoptic findings to help establish an early diagnosis.
2023
neurofibromatosis type 2 (NF2); merlin protein; cataract; epiretinal membrane; rare diseases
01 Pubblicazione su rivista::01a Articolo in rivista
Ophthalmic manifestation in neurofibromatosis type 2 / Armentano, Marta; Lucchino, Luca; Alisi, Ludovico; Chicca, ANTONIO VALERIO; DI MARTINO, Valerio; Miraglia, Emanuele; Iannetti, Ludovico; Comberiati, Anna Maria; Giustini, Sandra; Lambiase, Alessandro; Moramarco, Antonietta. - In: APPLIED SCIENCES. - ISSN 2076-3417. - 13:10(2023). [10.3390/app13106304]
File allegati a questo prodotto
File Dimensione Formato  
Armentano_Ophthalmic manifestation_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1680375
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact